Search details
1.
α-Glucosidase inhibition by green, white and oolong teas: in vitro activity and computational studies.
J Enzyme Inhib Med Chem
; 38(1): 2236802, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-37470394
2.
Synthesis, in silico modelling, and in vitro biological evaluation of substituted pyrazole derivatives as potential anti-skin cancer, anti-tyrosinase, and antioxidant agents.
J Enzyme Inhib Med Chem
; 38(1): 2205042, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-37184042
3.
Standardized Pomegranate (Pomella®) and Red Maple (Maplifa®) Extracts and Their Phenolics Protect Type I Collagen by the Inhibition of Matrix Metalloproteinases, Collagenase, and Collagen Cross-Linking.
Molecules
; 27(22)2022 Nov 16.
Article
in English
| MEDLINE | ID: mdl-36432019
4.
Synthesis, inverse docking-assisted identification and in vitro biological characterization of Flavonol-based analogs of fisetin as c-Kit, CDK2 and mTOR inhibitors against melanoma and non-melanoma skin cancers.
Bioorg Chem
; 107: 104595, 2021 02.
Article
in English
| MEDLINE | ID: mdl-33450548
5.
Multifaceted approach toward mapping out the anticancer properties of small molecules via in vitro evaluation on melanoma and nonmelanoma skin cancer cells, and in silico target fishing.
Chem Biol Drug Des
; 103(1): e14418, 2024 01.
Article
in English
| MEDLINE | ID: mdl-38230791
6.
The PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds.
Cells
; 12(12)2023 06 20.
Article
in English
| MEDLINE | ID: mdl-37371141
7.
Dual targeting of mTOR/IL-17A and autophagy by fisetin alleviates psoriasis-like skin inflammation.
Front Immunol
; 13: 1075804, 2022.
Article
in English
| MEDLINE | ID: mdl-36741386
8.
Identification of new fisetin analogs as kinase inhibitors: Data on synthesis and anti-skin cancer activities evaluation.
Data Brief
; 35: 106858, 2021 Apr.
Article
in English
| MEDLINE | ID: mdl-33665254
Results
1 -
8
de 8
1
Next >
>>